You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
CohBar appoints director
S&P Capital IQ Pro | Unrivaled Sector Coverage
S&P Capital IQ Pro | Powering Your Edge
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings
CohBar Inc. appointed John Amatruda to the board.
Amatruda is a co-founder and scientific adviser to the company. He is also currently on the board of CureDM, Prosciento, and Fractyl.
CohBar is a biotechnology company focused on the research and development of mitochondria-based therapeutics for age-related diseases.